This is what I've built my current startup on. We find that ideas, structures and molecules are cheap and actually making them in cells is the issue. Obviously this doesn't apply to small molecules but as groups like Anthropic move closer to Phase I I'm guessing we'll see a lot of frustration with existing CDMO providers like Wuxi or Lonza just like we see with Apple and their woes with Micron etc.